Efficacy of recombinant human interferon alpha-2b on experimental endometriosis

Devrim Altintas, Altintas D, Arif Kokcu, Arif Kökçü, Kokcu A, Tosun M, Migraci Tosun, Miğraci Tosun, Mehmet B Cetinkaya, Mehmet Çetinkaya, Cetinkaya MB, Bedrı Kandemır, Bedri Kandemir, Kandemir B
European journal of obstetrics, gynecology, and reproductive biology · 2007 · vol. 139(1) , pp. 95–99 · doi:10.1016/j.ejogrb.2007.09.006 · PMID:17961906 · W2094170162
Lab / animal OA: closed CC0 ⤵ 13 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated the efficacy of recombinant human interferon α-2b in an experimental model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To investigate the efficacy of recombinant human interferon alpha-2b on endometriosis. STUDY DESIGN: The randomized, placebo-controlled, single-blind, experimental study was performed on 30 Wistar female rats in the Experimental Surgery Laboratory at Ondokuz Mayis University in Turkey. After the peritoneal implantation of endometrial tissue, rats were randomized to two equal intervention groups: (1) the control group and (2) the interferon group. Six weeks later, after implant volume was measured (volume-1) by performing a second laparotomy, interferon alpha-2b (100,000 IU subcutaneously per rat, three times at 48 h intervals) was administered to the interferon group, and saline solution (0.1 ml SC, once per week), to the control group, for 8 weeks. At the end of the treatment, a third laparotomy was performed to remeasure implant volumes (volume-2), and implants were totally excised for histopathologic examination. Volume-1 and volume-2 within the groups, as well as stromal and glandular tissues between the groups were compared. RESULTS: In the interferon group, volume-2 was statistically significantly reduced compared with volume-1, whereas there was no significant volume change in the control group. In the interferon group, when compared with the control group, both stromal and glandular tissues had statistically significantly lessened. CONCLUSIONS: Interferon alpha-2b was seen to regress significantly both the size and the histological structure of endometriotic implants.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Angiogenesis Inhibitors Endometriosis Interferon-alpha Uterine Diseases Angiogenesis Inhibitors Angiogenesis Inhibitors Animals Animals Disease Models, Animal Disease Models, Animal Endometriosis Endometriosis Female Female Humans Humans Interferon-alpha Interferon-alpha Interferon alpha-2 Interferon alpha-2

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (24)

Cited by (14)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:04:47.165929+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK